| P2093 | author name string | Goa KL | |
| | Monk JP | |
| P2860 | cites work | Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester | Q28290166 |
| | Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. | Q34069536 |
| | Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease | Q39540382 |
| | Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer | Q39542302 |
| | Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial. | Q39544363 |
| | Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome | Q39741061 |
| | Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion | Q41891763 |
| | Effects of enprostil on platelets, endothelial cells, and other cell types, and second messenger systems by which these effects are mediated | Q41950512 |
| | Prostaglandins and cellular restitution in the gastric mucosa | Q42525595 |
| | Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia | Q43490492 |
| | Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. | Q51632993 |
| | Protective effects of the synthetic prostaglandin enprostil on the gastric microvasculature after ethanol injury in the rat. | Q52490373 |
| | Gastroduodenal mucosal secretion of bicarbonate and mucus. Physiologic control and stimulation by prostaglandins. | Q54423969 |
| | Protective effects of the prostaglandins on the gastric mucosa | Q68736632 |
| | Prostanoid inhibition of canine parietal cells | Q68973035 |
| | Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study | Q69936489 |
| | Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease | Q69954547 |
| | Platelet function in patients receiving enprostil | Q70011792 |
| | Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer | Q70074577 |
| | Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism | Q70292706 |
| | [Enprostil in the acute treatment of duodenal ulcer: direct comparative study with pirenzepin] | Q70296835 |
| | Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion | Q70304517 |
| | Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa | Q70304523 |
| | Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate | Q70304527 |
| | Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue | Q70304531 |
| | Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue | Q70304533 |
| | Comparison of enprostil and cimetidine in active duodenal ulcer disease. Summary of pooled European studies | Q70304536 |
| | Treatment of gastric ulcer with enprostil | Q70304539 |
| | Gastric mucosal binding studies with enprostil: a potent anti-ulcer prostaglandin | Q70317694 |
| | Stimulation of HCO3- secretion by the prostaglandin E2 analog enprostil: studies in human stomach and rat duodenum | Q70333779 |
| | Enprostil and cimetidine: comparative efficacy and safety in patients with duodenal ulcer | Q70343016 |
| | Influence of cigarette smoking on healing and relapse in duodenal ulcer disease | Q72559716 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peptic ulcer disease | Q172941 |
| | pharmacokinetics | Q323936 |
| | pharmacodynamics | Q725307 |
| P304 | page(s) | 539-559 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease | |
| P478 | volume | 34 | |